- |||||||||| ivermectin oral / Generic mfg.
Enrollment open, Trial initiation date: Ocular Changes After Ivermectin - (DOLF IVM/Oncho) (clinicaltrials.gov) - Oct 3, 2018 P=N/A, N=300, Enrolling by invitation, Active, not recruiting --> Completed Not yet recruiting --> Enrolling by invitation | Initiation date: May 2018 --> Aug 2018
- |||||||||| albendazole / Generic mfg.
Trial initiation date: Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) - Aug 13, 2018 P2/3, N=1960, Not yet recruiting, Not yet recruiting --> Enrolling by invitation | Initiation date: May 2018 --> Aug 2018 Initiation date: Jun 2018 --> Sep 2018
- |||||||||| albendazole / Generic mfg.
Enrollment open: Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) - May 25, 2017 P4, N=1440, Recruiting, Recruiting --> Active, not recruiting | N=400 --> 312 | Trial primary completion date: Dec 2017 --> May 2018 Not yet recruiting --> Recruiting
- |||||||||| albendazole / Generic mfg.
Trial initiation date: Twice Yearly Treatment for the Control of LF (clinicaltrials.gov) - Apr 17, 2017 P4, N=1440, Not yet recruiting, Not yet recruiting --> Recruiting Initiation date: Mar 2017 --> Jun 2017
|